PL2643344T3 - Peptyd pochodzący z ludzkiej laktoferyny do zastosowania jako środek maskujący antygen - Google Patents
Peptyd pochodzący z ludzkiej laktoferyny do zastosowania jako środek maskujący antygenInfo
- Publication number
- PL2643344T3 PL2643344T3 PL10784307T PL10784307T PL2643344T3 PL 2643344 T3 PL2643344 T3 PL 2643344T3 PL 10784307 T PL10784307 T PL 10784307T PL 10784307 T PL10784307 T PL 10784307T PL 2643344 T3 PL2643344 T3 PL 2643344T3
- Authority
- PL
- Poland
- Prior art keywords
- masking agent
- derived peptide
- human lactoferrin
- lactoferrin derived
- antigen masking
- Prior art date
Links
- 101000798114 Homo sapiens Lactotransferrin Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 102000050459 human LTF Human genes 0.000 title 1
- 230000000873 masking effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/644—Transferrin, e.g. a lactoferrin or ovotransferrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Marine Sciences & Fisheries (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2010/068302 WO2012069089A1 (en) | 2010-11-26 | 2010-11-26 | Human lactoferrin derived peptide for use as an antigen masking agent |
| EP10784307.0A EP2643344B1 (en) | 2010-11-26 | 2010-11-26 | Human lactoferrin derived peptide for use as an antigen masking agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2643344T3 true PL2643344T3 (pl) | 2017-09-29 |
Family
ID=43837881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10784307T PL2643344T3 (pl) | 2010-11-26 | 2010-11-26 | Peptyd pochodzący z ludzkiej laktoferyny do zastosowania jako środek maskujący antygen |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9724422B2 (pl) |
| EP (1) | EP2643344B1 (pl) |
| JP (1) | JP6073239B2 (pl) |
| KR (1) | KR101765364B1 (pl) |
| CN (1) | CN103906760B (pl) |
| AU (1) | AU2010364538B2 (pl) |
| BR (1) | BR112013012811B8 (pl) |
| CA (1) | CA2818951C (pl) |
| ES (1) | ES2627960T3 (pl) |
| HK (1) | HK1196379A1 (pl) |
| HU (1) | HUE033501T2 (pl) |
| IL (1) | IL226198B (pl) |
| MX (1) | MX348337B (pl) |
| PL (1) | PL2643344T3 (pl) |
| RU (1) | RU2573422C2 (pl) |
| SI (1) | SI2643344T1 (pl) |
| WO (1) | WO2012069089A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2767501T3 (es) | 2014-05-28 | 2020-06-17 | Evonik Operations Gmbh | Nanopartícula |
| JP2019508036A (ja) | 2016-02-16 | 2019-03-28 | ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド | 免疫療法組成物及び方法 |
| DE102016008601B4 (de) | 2016-07-14 | 2019-05-23 | Giesecke+Devrient Currency Technology Gmbh | Sicherheitselement mit reversibel veränderbarem Farbbereich |
| US11021529B2 (en) | 2017-03-03 | 2021-06-01 | Massachusetts Institute Of Technology | Antimicrobial constructs and uses thereof |
| CN107226860B (zh) * | 2017-07-06 | 2020-04-10 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽skhssldcvl及其制备方法和应用 |
| JP2021523137A (ja) | 2018-05-08 | 2021-09-02 | エボニック オペレーションズ ゲーエムベーハー | 生体吸収性ポリエステル、親水性ポリマーおよびアシル化ヒトラクトフェリン由来ペプチドを含むナノ粒子 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6066469A (en) * | 1990-03-08 | 2000-05-23 | Ferro Dynamics, Inc. | Cloning, expression, and uses of human lactoferrin |
| US5977337A (en) | 1997-06-03 | 1999-11-02 | Connaught Laboratories Limited | Lactoferrin receptor genes of Moraxella |
| JP3681982B2 (ja) | 1998-07-15 | 2005-08-10 | サムヤン ジェネックス コーポレイション | 酵母からラクトフェリンポリペプチドを大量生産する方法及びそれに有用な微生物菌株 |
| JP2000045182A (ja) | 1998-07-23 | 2000-02-15 | Peptide Science:Kk | 抗菌性繊維および繊維・皮革用抗菌加工剤 |
| US20070259007A1 (en) * | 1999-10-19 | 2007-11-08 | Kruzel Marian L | Lactoferrin: an adjuvant for vaccines |
| RU2165769C1 (ru) | 2000-07-13 | 2001-04-27 | Якубовская Раиса Ивановна | Антибактериальный, антиоксидантный, иммуномодулирующий и антиканцерогенный препарат и способ его применения |
| ATE395596T1 (de) | 2002-10-25 | 2008-05-15 | Techlab Inc | Diagnostisches panel ibd-first chek fur entzundliche darmerkrankung (ibd) und reizkolon |
| WO2004052305A2 (en) | 2002-12-10 | 2004-06-24 | Agennix Incorporated | Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
| DE102005051366A1 (de) | 2005-10-25 | 2007-04-26 | Degussa Gmbh | Drug Delivery Systeme |
| CN101395180B (zh) * | 2005-12-30 | 2016-06-22 | 赢创罗姆有限责任公司 | 用作细胞穿膜肽的肽 |
-
2010
- 2010-11-26 CA CA2818951A patent/CA2818951C/en active Active
- 2010-11-26 KR KR1020137016498A patent/KR101765364B1/ko active IP Right Grant
- 2010-11-26 US US13/988,829 patent/US9724422B2/en active Active
- 2010-11-26 JP JP2013540244A patent/JP6073239B2/ja active Active
- 2010-11-26 AU AU2010364538A patent/AU2010364538B2/en active Active
- 2010-11-26 BR BR112013012811A patent/BR112013012811B8/pt active IP Right Grant
- 2010-11-26 EP EP10784307.0A patent/EP2643344B1/en active Active
- 2010-11-26 WO PCT/EP2010/068302 patent/WO2012069089A1/en active Application Filing
- 2010-11-26 RU RU2013128884/10A patent/RU2573422C2/ru active
- 2010-11-26 ES ES10784307.0T patent/ES2627960T3/es active Active
- 2010-11-26 SI SI201031471A patent/SI2643344T1/sl unknown
- 2010-11-26 CN CN201080070362.8A patent/CN103906760B/zh active Active
- 2010-11-26 PL PL10784307T patent/PL2643344T3/pl unknown
- 2010-11-26 MX MX2013005820A patent/MX348337B/es active IP Right Grant
- 2010-11-26 HU HUE10784307A patent/HUE033501T2/en unknown
-
2013
- 2013-05-07 IL IL226198A patent/IL226198B/en active IP Right Grant
-
2014
- 2014-09-26 HK HK14109719.5A patent/HK1196379A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR101765364B1 (ko) | 2017-08-08 |
| CA2818951C (en) | 2018-03-13 |
| WO2012069089A1 (en) | 2012-05-31 |
| BR112013012811A2 (pt) | 2016-09-13 |
| JP2014501723A (ja) | 2014-01-23 |
| RU2573422C2 (ru) | 2016-01-20 |
| BR112013012811B8 (pt) | 2022-07-05 |
| EP2643344B1 (en) | 2017-03-22 |
| AU2010364538A1 (en) | 2013-07-11 |
| US20130302342A1 (en) | 2013-11-14 |
| CN103906760B (zh) | 2017-02-22 |
| HK1196379A1 (zh) | 2014-12-12 |
| SI2643344T1 (sl) | 2017-07-31 |
| ES2627960T3 (es) | 2017-08-01 |
| KR20130119955A (ko) | 2013-11-01 |
| HUE033501T2 (en) | 2017-12-28 |
| IL226198A0 (en) | 2013-07-31 |
| EP2643344A1 (en) | 2013-10-02 |
| US9724422B2 (en) | 2017-08-08 |
| BR112013012811B1 (pt) | 2021-07-06 |
| CA2818951A1 (en) | 2012-05-31 |
| JP6073239B2 (ja) | 2017-02-01 |
| MX2013005820A (es) | 2013-07-12 |
| MX348337B (es) | 2017-06-07 |
| RU2013128884A (ru) | 2015-01-10 |
| AU2010364538B2 (en) | 2016-04-14 |
| CN103906760A (zh) | 2014-07-02 |
| IL226198B (en) | 2019-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181320T8 (hr) | Ljudska anti-tau protutijela | |
| LT2580243T (lt) | Antikūnai prieš žmogaus cd38 | |
| ZA201206832B (en) | Novel peptides and method for their preparation and use | |
| ZA201307641B (en) | Human tissue factor antibody and uses thereof | |
| EP2588127A4 (en) | DIPEPTIDE-NETWORKED MEDICAL ACTIVE SUBSTANCES | |
| PL2588491T3 (pl) | Nowy peptyd i jego zastosowanie | |
| EP2738255A4 (en) | PEPTIDE FROM ERAP1 AND ITS USE | |
| HK1196379A1 (zh) | 用作抗原掩蔽劑的人乳鐵蛋白衍生肽 | |
| EP2621955A4 (en) | ANTI-CEACAM6 ANTIBODIES AND USES THEREOF | |
| ZA201305591B (en) | Fluorocarbon-linked peptide formulation | |
| PT2768848T (pt) | Agentes e métodos para a expressão e secreção de péptidos e proteínas | |
| PL2668205T3 (pl) | Peptydy pochodzące z ludzkiej laktoferyny i ich zastosowanie | |
| IL223292A0 (en) | Stabilized human immunoglobulin composition | |
| PL2627668T3 (pl) | Peptydy i ich zastosowanie | |
| HK1168622A1 (en) | Antigen peptide and use thereof | |
| EP2575869A4 (en) | PEPTIDE PARTICLE FORMULATION | |
| EP2762149A4 (en) | PEPTIDE DERIVED FROM ERYTHROPOIETIN AND USE THEREOF | |
| EP2660249A4 (en) | PEPTIDE DERIVATIVE AND USE THEREOF | |
| EP2521787A4 (en) | IMPROVED PROTEIN EXPRESSION | |
| PL2555790T3 (pl) | ZASTOSOWANIE LECZNICZE ß2-MIKROGLOBULINY | |
| HUE048721T2 (hu) | Humán CD38 elleni ellenanyagok | |
| IL226635B (en) | Human anti-sod1 antibodies | |
| GB201019523D0 (en) | Skin testing | |
| GB201006953D0 (en) | Skin testing | |
| GB201005609D0 (en) | Hairdresser's masking aid |